Skip to main content

5 articles related to "Programmed Death Ligand 1pd L1"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Case Report

Published on 07 Nov 2024

Case report: Combination therapy of envafolimab with endostar for advanced non-small cell lung cancer with low PD-L1 expression

in Thoracic Oncology

Shuo Wu
Changhong Dong
Chenxi Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1437260

2,025 views
2 citations

Original Research

Published on 03 Sep 2021

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma

in Cancer Immunity and Immunotherapy

Ziqi Huang
Baihui Li
Yan Guo
Lei Wu
Fan Kou
Lili Yang

Frontiers in Immunology

doi 10.3389/fimmu.2021.723172

6,582 views
19 citations

Original Research

Published on 15 Oct 2018

A Probiotic Mixture Regulates T Cell Balance and Reduces Atopic Dermatitis Symptoms in Mice

in Food Microbiology

Han Wool Kim
Rira Hong
Eun Young Choi
KeeSun Yu
Narae Kim
Jin Yi Hyeon
Kwang Keun Cho
In Soon Choi
Cheol-Heui Yun

Frontiers in Microbiology

doi 10.3389/fmicb.2018.02414

14,304 views
52 citations

Review

Published on 14 Feb 2023

Efficacy and safety of treatment regimens for patients with metastatic, locally advanced, or recurrent breast cancer carrying BRCA1/BRCA2 pathogenic variants: A network meta-analysis

in Breast Cancer

Yingxuan Zhu
Yang Li
Weida Liu
Ruozhu Zhou
Lap Ah Tse
Yang Wang
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1080297

4,030 views
3 citations

Systematic Review

Published on 11 Jul 2024

Comparative long-term outcomes of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy as first-line therapy for metastatic non-small-cell lung cancer: a systematic review and network meta-analysis

in Cancer Immunity and Immunotherapy

Shibo Huang
Zhilong Huang
Xiaolong Huang
Raoshan Luo
Weiming Liang
Tian Qin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1375136

8,336 views
13 citations